Citations (229)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Saeed Asadzadeh Bayqara, Mohammadreza Aghazadeh Yamchelu, Sheyda Abdolahzadeyadegari, Mona Farhadi, Shabnam Nadjafi, Javad fahanik Babaei & Nasrin Hosseini. (2022) The effects of a chalcone derivative on memory, hippocampal corticosterone and BDNF levels in adult rats. International Journal of Neuroscience 0:0, pages 1-10.
Read now
Read now
Mônica Villa Nova, Kennard Gan & Matthias G. Wacker. (2022) Biopredictive tools for the development of injectable drug products. Expert Opinion on Drug Delivery 19:6, pages 671-684.
Read now
Read now
Jie Wang, Weiwei Hu, Zehua Feng & Meijiang Feng. (2021) BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice. Neurological Research 43:3, pages 199-209.
Read now
Read now
Peter Deng, Johnathon D. Anderson, Abigail S. Yu, Geralyn Annett, Kyle D. Fink & Jan A. Nolta. (2016) Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opinion on Biological Therapy 16:8, pages 1025-1033.
Read now
Read now
Namita A Goyal & Tahseen Mozaffar. (2014) Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs. Expert Opinion on Investigational Drugs 23:11, pages 1541-1551.
Read now
Read now
Philip Van Damme & Wim Robberecht. (2014) Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery. Expert Opinion on Investigational Drugs 23:7, pages 955-963.
Read now
Read now
Thomas A. Lanz, Susan E. Bove, Catherine D. Pilsmaker, Abigail Mariga, Elena M. Drummond, Gregory W. Cadelina, Wendy O. Adamowicz, Brentt J. Swetter, Sharon Carmel, Jo Ann Dumin & Robin J. Kleiman. (2012) Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma. Biomarkers 17:6, pages 524-531.
Read now
Read now
D. Poston, R. Raghavan & G. T. Gillies. (2011) Catheter delivery systems for infusions into the cortex. Journal of Medical Engineering & Technology 35:5, pages 246-253.
Read now
Read now
Magdalena Kuzma-Kozakiewicz & Hubert Kwiecinski. (2011) New therapeutic targets for amyotrophic lateral sclerosis. Expert Opinion on Therapeutic Targets 15:2, pages 127-143.
Read now
Read now
Toru Yasuda & Hideki Mochizuki. (2010) Use of growth factors for the treatment of Parkinson’s disease. Expert Review of Neurotherapeutics 10:6, pages 915-924.
Read now
Read now
Stefano Zoccolella, Andrea Santamato & Paolo Lamberti. (2009) Current and emerging treatments for amyotrophic lateral sclerosis. Neuropsychiatric Disease and Treatment 5, pages 577-595.
Read now
Read now
Ceryl A. Harwood, Christopher J. McDermott & Pamela J. Shaw. (2009) Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence. Amyotrophic Lateral Sclerosis 10:4, pages 191-204.
Read now
Read now
J. Simon Lunn, Michael P. Hefferan, Martin Marsala & Eva L. Feldman. (2009) Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors 27:3, pages 133-140.
Read now
Read now
Vassilis E Koliatsos, Leyan Xu & Jun Yan. (2008) Human stem cell grafts as therapies for motor neuron disease. Expert Opinion on Biological Therapy 8:2, pages 137-141.
Read now
Read now
Isao Nagano, Mito Shiote, Tetsuro Murakami, Hiroshi Kamada, Yoshiyuki Hamakawa, Etsuro Matsubara, Masataka Yokoyama, Kiyoshi Morita, Mikio Shoji & Koji Abe. (2005) Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurological Research 27:7, pages 768-772.
Read now
Read now
Marcus Beck, Peter Flachenecker, Tim Magnus, Ralf Giess, Karlheinz Reiners, Klaus V. Toyka & Markus Naumann. (2005) Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF. Amyotrophic Lateral Sclerosis 6:2, pages 100-103.
Read now
Read now
Michael D Weiss, Patrick Weydt & Gregory T Carter. (2004) Current pharmacological management of amyotropic lateral sclerosis and a role for rational polypharmacy. Expert Opinion on Pharmacotherapy 5:4, pages 735-746.
Read now
Read now
Claude Brodski, Daniela M Vogt Weisenhorn & Georg Dechant. (2002) Therapy of neurodegenerative diseases using neurotrophic factors: cell biological perspective. Expert Review of Neurotherapeutics 2:3, pages 417-426.
Read now
Read now
Articles from other publishers (211)
Marta Zagrebelsky & Martin Korte. (2024) Are TrkB receptor agonists the right tool to fulfill the promises for a therapeutic value of the brain-derived neurotrophic factor?. Neural Regeneration Research 19:1, pages 29-34.
Crossref
Crossref
Mingliang Xu, Lei Xia, Junjie Li, Yehong Du & Zhifang Dong. (2024) 7,8-Dihydroxyflavone ameliorates cognitive impairment induced by repeated neonatal sevoflurane exposures in mice through increasing tau O-GlcNAcylation. Neuroscience Letters 818, pages 137559.
Crossref
Crossref
Junhua Xiao. (2023)
Thirty years of
BDNF
study in central myelination: From biology to therapy
. Journal of Neurochemistry 167:3, pages 321-336.
Crossref
Crossref
Nicholas J. Maragakis, Mamede de Carvalho & Michael D. Weiss. (2023)
Therapeutic targeting of
ALS
pathways: Refocusing an incomplete picture
. Annals of Clinical and Translational Neurology 10:11, pages 1948-1971.
Crossref
Crossref
Wesley M. Stansberry & Brian A. Pierchala. (2023) Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Douglas W. Zochodne. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment
569
598
.
Carlye A. Szarowicz, Kathy Steece-Collier & Margaret E. Caulfield. (2022) New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism. International Journal of Molecular Sciences 23:14, pages 8011.
Crossref
Crossref
Seong Su Kang, Zhourui Wu, Xia Liu, Laura Edgington-Mitchell & Keqiang Ye. (2022) Treating Parkinson’s Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase. Neurotherapeutics 19:4, pages 1283-1297.
Crossref
Crossref
Khairunnuur Fairuz Azman & Rahimah Zakaria. (2022) Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases. International Journal of Molecular Sciences 23:12, pages 6827.
Crossref
Crossref
Lidawani Lambuk, Mohd Aizuddin Mohd Lazaldin, Suhana Ahmad, Igor Iezhitsa, Renu Agarwal, Vuk Uskoković & Rohimah Mohamud. (2022) Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art. Frontiers in Pharmacology 13.
Crossref
Crossref
Pietro Renna, Cristian Ripoli, Onur Dagliyan, Francesco Pastore, Marco Rinaudo, Agnese Re, Fabiola Paciello & Claudio Grassi. (2022)
Engineering a switchable single‐chain
TEV
protease to control protein maturation in living neurons
. Bioengineering & Translational Medicine 7:2.
Crossref
Crossref
Lino Tessarollo & Sudhirkumar Yanpallewar. (2022) TrkB Truncated Isoform Receptors as Transducers and Determinants of BDNF Functions. Frontiers in Neuroscience 16.
Crossref
Crossref
Qinxiang Zhou, Hao Tang, Dingqun Bai & Yuhan Kong. (2022) 7,8-Dihydroxyflavone protects neurons against oxygen-glucose deprivation induced apoptosis and activates the TrkB/Akt pathway. PeerJ 10, pages e12886.
Crossref
Crossref
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1893
1929
.
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
37
.
Maria Carmela Di Rosa, Stefania Zimbone, Miriam Wissam Saab & Marianna Flora Tomasello. (2021) The Pleiotropic Potential of BDNF beyond Neurons: Implication for a Healthy Mind in a Healthy Body. Life 11:11, pages 1256.
Crossref
Crossref
Anna Sobuś, Bartłomiej Baumert, Monika Gołąb-Janowska, Piotr Kulig, Edyta Paczkowska, Karolina Łuczkowska, Dorota Rogińska, Alicja Zawiślak, Sławomir Milczarek, Bogumiła Osękowska, Wioletta Pawlukowska, Agnieszka Meller, Karolina Machowska-Sempruch, Agnieszka Wełnicka, Przemysław Nowacki & Bogusław Machaliński. (2021) Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients. Journal of Clinical Medicine 10:22, pages 5251.
Crossref
Crossref
Frank Bicker, Leonardo Nardi, Jannik Maier, Verica Vasic & Michael J. Schmeisser. (2021) Criss‐crossing autism spectrum disorder and adult neurogenesis. Journal of Neurochemistry 159:3, pages 452-478.
Crossref
Crossref
Li Zuo, Chunfang Dai, Lilin Yi & Zhifang Dong. (2021) 7,8-dihydroxyflavone ameliorates motor deficits via regulating autophagy in MPTP-induced mouse model of Parkinson’s disease. Cell Death Discovery 7:1.
Crossref
Crossref
Yuanyuan Huang, Dangwei Peng, Hao Geng, Yutian Dai, Hui Jiang & Xiansheng Zhang. (2021)
Endogenous Deficiency of Brain-Derived Neurotrophic Factor Induces the Downregulation of
Tryptophan Hydroxylase-2
Expression in Raphe Nuclei of Rapid Ejaculator Rats
. The Journal of Sexual Medicine 18:9, pages 1491-1499.
Crossref
Crossref
Chun Chen, Eun H. Ahn, Xia Liu, Zhi-Hao Wang, Shilin Luo, Jianming Liao & Keqiang Ye. (2021) Optimized TrkB Agonist Ameliorates Alzheimer’s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase. ACS Chemical Neuroscience 12:13, pages 2448-2461.
Crossref
Crossref
Fan Xue, Zhenlei Zhao, Yanpei Gu, Jianxin Han, Keqiang Ye & Ying Zhang. (2021) 7,8-Dihydroxyflavone modulates bone formation and resorption and ameliorates ovariectomy-induced osteoporosis. eLife 10.
Crossref
Crossref
Farzaneh Modarresi, Roya Pedram Fatemi, Seyedeh Fatemeh Razavipour, Natalie Ricciardi, Madina Makhmutova, Nathalie Khoury, Marco Magistri, Claude-Henry Volmar, Claes Wahlestedt & Mohammad Ali Faghihi. (2021) A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function following exercise. Heliyon 7:7, pages e07570.
Crossref
Crossref
Efthalia Angelopoulou, Yam Nath Paudel & Christina Piperi. (2021) Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities. Molecular Neurobiology 58:7, pages 3031-3042.
Crossref
Crossref
Ghazal Naseri Kouzehgarani, Thomas Feldsien, Herbert H. Engelhard, Kuldip K. Mirakhur, Colin Phipps, Volker Nimmrich, Diana Clausznitzer & Didier R. Lefebvre. (2021) Harnessing cerebrospinal fluid circulation for drug delivery to brain tissues. Advanced Drug Delivery Reviews 173, pages 20-59.
Crossref
Crossref
Grishma Pawar, Neha N. Parayath, Aditya A. Sharma, Carlos Coito, Olga Khorkova, Jane Hsiao, William T. Curry, Mansoor M. Amiji & Benjamin S. Bleier. (2021) Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting. Frontiers in Pharmacology 12.
Crossref
Crossref
Anisha D'Souza, Kandarp M. Dave, R. Anne Stetler & Devika S. Manickam. (2021) Targeting the blood-brain barrier for the delivery of stroke therapies. Advanced Drug Delivery Reviews 171, pages 332-351.
Crossref
Crossref
Sudhirkumar Yanpallewar, Gianluca Fulgenzi, Francesco Tomassoni-Ardori, Colleen Barrick & Lino Tessarollo. (2021) Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous. Experimental Neurology 337, pages 113576.
Crossref
Crossref
Haifa Alkhalifa, Esraa Alshebber & Sebastien Taurin. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
259
287
.
Ceren Eyileten, Lucia Sharif, Zofia Wicik, Daniel Jakubik, Joanna Jarosz-Popek, Aleksandra Soplinska, Marek Postula, Anna Czlonkowska, Agnieszka Kaplon-Cieslicka & Dagmara Mirowska-Guzel. (2020) The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke. Molecular Neurobiology 58:1, pages 329-347.
Crossref
Crossref
Fabiana Mallone, Marta Sacchetti, Alice Bruscolini, Luca Scuderi, Marco Marenco & Alessandro Lambiase. (2020) Neurotrophic Factors in Glaucoma and Innovative Delivery Systems. Applied Sciences 10:24, pages 9015.
Crossref
Crossref
Brian W. Blakley, Michael Seaman & Abdulrahman Alenezi. (2020) Brain-derived nerve growth factor in the cochlea – a reproducibility study. Journal of Otolaryngology - Head & Neck Surgery 49:1.
Crossref
Crossref
Sahabuddin Ahmed, Mohit Kwatra, Basveshwar Gawali, Samir Ranjan Panda & V. G. M. Naidu. (2020) Potential role of TrkB agonist in neuronal survival by promoting CREB/BDNF and PI3K/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death. Apoptosis.
Crossref
Crossref
Francesca Marchionne, Alexander J. Krupka, George M. Smith & Michel A. Lemay. (2020) Intrathecal Delivery of BDNF Into the Lumbar Cistern Re-Engages Locomotor Stepping After Spinal Cord Injury. IEEE Transactions on Neural Systems and Rehabilitation Engineering 28:11, pages 2459-2467.
Crossref
Crossref
Chia-Hao Fan, Chia-Wei Lin, Hei-Jen Huang, Guey-Jen Lee-Chen, Ying-Chieh Sun, Wenwei Lin, Chiung-Mei Chen, Kuo-Hsuan Chang, Ming-Tsan Su & Hsiu Mei Hsieh-Li. (2020) LMDS-1, a potential TrkB receptor agonist provides a safe and neurotrophic effect for early-phase Alzheimer’s disease. Psychopharmacology 237:10, pages 3173-3190.
Crossref
Crossref
Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang & Shilin Luo. (2020)
Bushen-Tiansui Formula Improves Cognitive Functions in an A
β
1–42
Fibril-Infused Rat Model of Alzheimer’s Disease
. Neural Plasticity 2020, pages 1-11.
Crossref
Crossref
G.Y. Wang, S.L. Rayner, R. Chung, B.Y. Shi & X.J. Liang. (2020) Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis. Materials Today Bio 6, pages 100055.
Crossref
Crossref
Ewelina Palasz, Adrianna Wysocka, Anna Gasiorowska, Malgorzata Chalimoniuk, Wiktor Niewiadomski & Grazyna Niewiadomska. (2020) BDNF as a Promising Therapeutic Agent in Parkinson’s Disease. International Journal of Molecular Sciences 21:3, pages 1170.
Crossref
Crossref
Seaab Sahib, Aruna Sharma, Preeti K. Menon, Dafin F. Muresanu, Ala Nozari, José Vicente Lafuente, Igor Bryukhovetskiy, Z. Ryan Tian, Ranjana Patnaik, Anca D. Buzoianu, Lars Wiklund & Hari Shanker Sharma. 2020. Neuropharmacology of Neuroprotection. Neuropharmacology of Neuroprotection
397
438
.
Maria A. Lanuza, Laia Just-Borràs, Erica Hurtado, Víctor Cilleros-Mañé, Marta Tomàs, Neus Garcia & Josep Tomàs. (2019) The Impact of Kinases in Amyotrophic Lateral Sclerosis at the Neuromuscular Synapse: Insights into BDNF/TrkB and PKC Signaling. Cells 8:12, pages 1578.
Crossref
Crossref
Antonello Spinelli, Maria Girelli, Daniela Arosio, Laura Polito, Paola Podini, Gianvito Martino, Pierfausto Seneci, Luca Muzio & Andrea Menegon. (2019) Intracisternal delivery of PEG-coated gold nanoparticles results in high brain penetrance and long-lasting stability. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Wei Guo, Keliang Pang, Yanbo Chen, Shudan Wang, Heng Li, Yihua Xu, Fang Han, Hongyang Yao, Hang Liu, Vanessa Lopes-Rodrigues, Dang Sun, Jingyu Shao, Jianying Shen, Yang Dou, Wen Zhang, He You, Wutian Wu & Bai Lu. (2019) TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration. Neurobiology of Disease 132, pages 104590.
Crossref
Crossref
L. F. Zainullina, T. A. Gudasheva, Yu. V. Vakhitova & S. B. Seredenin. (2020) Low-Molecular-Weight Compound GSB-106 Mimics the Cellular Effects of BDNF after Serum Deprivation. Doklady Biochemistry and Biophysics 489:1, pages 396-398.
Crossref
Crossref
Stephanie Szobota, Pranav D. Mathur, Sairey Siegel, KristenAnn Black, H. Uri Saragovi & Alan C. Foster. (2019) BDNF, NT-3 and Trk receptor agonist monoclonal antibodies promote neuron survival, neurite extension, and synapse restoration in rat cochlea ex vivo models relevant for hidden hearing loss. PLOS ONE 14:10, pages e0224022.
Crossref
Crossref
Sweta Bawari, Devesh Tewari, Sandro Argüelles, Archana N. Sah, Seyed Fazel Nabavi, Suowen Xu, Rosa Anna Vacca, Seyed Mohammad Nabavi & Samira Shirooie. (2019) Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders. Pharmacological Research 148, pages 104458.
Crossref
Crossref
Laia Just-Borràs, Erica Hurtado, Víctor Cilleros-Mañé, Olivier Biondi, Frédéric Charbonnier, Marta Tomàs, Neus Garcia, Maria A. Lanuza & Josep Tomàs. (2019) Overview of Impaired BDNF Signaling, Their Coupled Downstream Serine-Threonine Kinases and SNARE/SM Complex in the Neuromuscular Junction of the Amyotrophic Lateral Sclerosis Model SOD1-G93A Mice. Molecular Neurobiology 56:10, pages 6856-6872.
Crossref
Crossref
Kulam Najmudeen Magdoom, Alec Brown, Julian Rey, Thomas H. Mareci, Michael A. King & Malisa Sarntinoranont. (2019) MRI of Whole Rat Brain Perivascular Network Reveals Role for Ventricles in Brain Waste Clearance. Scientific Reports 9:1.
Crossref
Crossref
Josh Houlton, Nashat Abumaria, Simon F. R. Hinkley & Andrew N. Clarkson. (2019) Therapeutic Potential of Neurotrophins for Repair After Brain Injury: A Helping Hand From Biomaterials. Frontiers in Neuroscience 13.
Crossref
Crossref
Flore Gouel, Anne-Sophie Rolland, Jean-Christophe Devedjian, Thierry Burnouf & David Devos. (2019) Past and Future of Neurotrophic Growth Factors Therapies in ALS: From Single Neurotrophic Growth Factor to Stem Cells and Human Platelet Lysates. Frontiers in Neurology 10.
Crossref
Crossref
Fang Han, Xiaoming Guan, Wei Guo & Bai Lu. (2019) Therapeutic potential of a TrkB agonistic antibody for ischemic brain injury. Neurobiology of Disease 127, pages 570-581.
Crossref
Crossref
Sareh Pandamooz, Mohammad Saied Salehi, Anahid Safari, Negar Azarpira, Mansooreh Heravi, Abolhassan Ahmadiani & Leila Dargahi. (2019) Enhancing the expression of neurotrophic factors in epidermal neural crest stem cells by valproic acid: A potential candidate for combinatorial treatment. Neuroscience Letters 704, pages 8-14.
Crossref
Crossref
Nathan P. Staff, David T. Jones & Wolfgang Singer. (2019) Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases. Mayo Clinic Proceedings 94:5, pages 892-905.
Crossref
Crossref
Hitoshi Warita, Masaaki Kato, Ryuta Asada, Atsuko Yamashita, Daichika Hayata, Kiichi Adachi & Masashi Aoki. (2018) Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP‐100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial. The Journal of Clinical Pharmacology 59:5, pages 677-687.
Crossref
Crossref
Mervin Chávez-Castillo, Victoria Núñez, Manuel Nava, Ángel Ortega, Milagros Rojas, Valmore Bermúdez & Joselyn Rojas-Quintero. (2019) Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. Advances in Pharmacological Sciences 2019, pages 1-20.
Crossref
Crossref
Dila Zafer, Nur Aycan, Burak Ozaydin, Pinar Kemanli, Peter Ferrazzano, Jon E. Levine & Pelin Cengiz. (2019) Sex differences in Hippocampal Memory and Learning following Neonatal Brain Injury: Is There a Role for Estrogen Receptor-α?. Neuroendocrinology 109:3, pages 249-256.
Crossref
Crossref
Mikhail Papisov & Vasily Belov. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery
251
274
.
Lingbin Meng, Baoqiong Liu, Rui Ji, Xin Jiang, Xuebo Yan & Ying Xin. (2018) Targeting the BDNF/TrkB pathway for the treatment of tumors (Review). Oncology Letters.
Crossref
Crossref
Alexandra N. Edelbrock, Zaida Àlvarez, Dina Simkin, Timmy Fyrner, Stacey M. Chin, Kohei Sato, Evangelos Kiskinis & Samuel I. Stupp. (2018) Supramolecular Nanostructure Activates TrkB Receptor Signaling of Neuronal Cells by Mimicking Brain-Derived Neurotrophic Factor. Nano Letters 18:10, pages 6237-6247.
Crossref
Crossref
Dian-Shi Wang, Kirusanthy Kaneshwaran, Gang Lei, Fariya Mostafa, Junhui Wang, Irene Lecker, Sinziana Avramescu, Yu-Feng Xie, Nathan K. Chan, Alejandro Fernandez-Escobar, Junsung Woo, Darren Chan, Amy J. Ramsey, Jeremy M. Sivak, C. Justin Lee, Robert P. Bonin & Beverley A. Orser. (2018) Dexmedetomidine Prevents Excessive γ-Aminobutyric Acid Type A Receptor Function after Anesthesia. Anesthesiology 129:3, pages 477-489.
Crossref
Crossref
Marion J. F. Levy, Fabien Boulle, Harry W. Steinbusch, Daniël L. A. van den Hove, Gunter Kenis & Laurence Lanfumey. (2018) Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression. Psychopharmacology 235:8, pages 2195-2220.
Crossref
Crossref
Spyros MerkourisYves-Alain Barde, Kate E. BinleyNicholas D. AllenAlexey V. StepanovNicholas C. WuGeramie GrandeChih-Wei LinMeng LiXinsheng NanPedro Chacon-FernandezPeter S. DiStefano, Ronald M. Lindsay, Richard A. LernerJia Xie. (2018) Fully human agonist antibodies to TrkB using autocrine cell-based selection from a combinatorial antibody library. Proceedings of the National Academy of Sciences 115:30.
Crossref
Crossref
Hsiu-Mei Huang, Chao-Ching Huang, Meng-Han Tsai, Yi-Chieh Poon & Ying-Chao Chang. (2018) Systemic 7,8-Dihydroxyflavone Treatment Protects Immature Retinas Against Hypoxic-Ischemic Injury via Müller Glia Regeneration and MAPK/ERK Activation. Investigative Opthalmology & Visual Science 59:7, pages 3124.
Crossref
Crossref
Qixian Zhang, Xiaoyang Li, Ru He, Quanhong Ma, Rui Sun, Shengjun Ji, Bei Wang & Ye Tian. (2018) The effect of brain-derived neurotrophic factor on radiation-induced neuron architecture impairment is associated with the NFATc4/3 pathway. Brain Research 1681, pages 21-27.
Crossref
Crossref
Conor Daly, Rebecca Ward, Alison L. Reynolds, Orla Galvin, Ross F. Collery & Breandán N. Kennedy. 2018. Retinal Degenerative Diseases. Retinal Degenerative Diseases
465
471
.
Danielle A. Simmons. (2017) Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease. Journal of Huntington's Disease 6:4, pages 303-325.
Crossref
Crossref
Loqman A. Mohamed, Shashirekha Markandaiah, Silvia Bonanno, Piera Pasinelli & Davide Trotti. (2017) Blood–Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies. The AAPS Journal 19:6, pages 1600-1614.
Crossref
Crossref
Rosendo G. Hernández, Silvia Silva-Hucha, Sara Morcuende, Rosa R. de la Cruz, Angel M. Pastor & Beatriz Benítez-Temiño. (2017) Extraocular Motor System Exhibits a Higher Expression of Neurotrophins When Compared with Other Brainstem Motor Systems. Frontiers in Neuroscience 11.
Crossref
Crossref
Lianping Xu, Danyang Tian, Jiao Li, Lu Chen, Lu Tang & Dongsheng Fan. (2017) The Analysis of Two BDNF Polymorphisms G196A/C270T in Chinese Sporadic Amyotrophic Lateral Sclerosis. Frontiers in Aging Neuroscience 9.
Crossref
Crossref
Dariusz Kotl?ga, Barbara Peda, Agnieszka Zembro?-?acny, Monika Go??b-Janowska & Przemys?aw Nowacki. (2017) The role of brain-derived neurotrophic factor and its single nucleotide polymorphisms in stroke patients. Neurologia i Neurochirurgia Polska 51:3, pages 240-246.
Crossref
Crossref
Nadhir Litim, Marc Morissette & Thérèse Di Paolo. (2017) Effects of progesterone administered after MPTP on dopaminergic neurons of male mice. Neuropharmacology 117, pages 209-218.
Crossref
Crossref
Syed Faraz Kazim, Julie Blanchard, Riccardo Bianchi & Khalid Iqbal. (2017) Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer’s-like memory deficits in the Ts65Dn mouse model of Down syndrome. Scientific Reports 7:1.
Crossref
Crossref
Chiu-Yen Chung, Martin Lin, I-Neng Lee, Tsong-Hai Lee, Ming-Hsueh Lee & Jen-Tsung Yang. (2017) Brain-Derived Neurotrophic Factor Loaded PS80 PBCA Nanocarrier for In Vitro Neural Differentiation of Mouse Induced Pluripotent Stem Cells. International Journal of Molecular Sciences 18:3, pages 663.
Crossref
Crossref
Kathleen Keefe, Imran Sheikh & George Smith. (2017) Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. International Journal of Molecular Sciences 18:3, pages 548.
Crossref
Crossref
Gonzalo Tejeda & Margarita Díaz-Guerra. (2017) Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies. International Journal of Molecular Sciences 18:2, pages 268.
Crossref
Crossref
TuaneBazanella Sampaio, AnneSuely Savall, MariaEduarda Ziani Gutierrez & Simone Pinton. (2017) Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy. Neural Regeneration Research 12:4, pages 549.
Crossref
Crossref
Shanmukha Shruthi, R. Sumitha, Anu Mary Varghese, S. Ashok, B.K. Chandrasekhar Sagar, T.N. Sathyaprabha, A. Nalini, Boris W. Kramer, Trichur R. Raju, K. Vijayalakshmi & Phalguni Anand Alladi. (2017) Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line. Neurodegenerative Diseases 17:1, pages 44-58.
Crossref
Crossref
Sylvia Josephy-Hernandez, Sean Jmaeff, Iulia Pirvulescu, Tahar Aboulkassim & H. Uri Saragovi. (2017) Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiology of Disease 97, pages 139-155.
Crossref
Crossref
Raymond T. Bartus & Eugene M. JohnsonJr.Jr.. (2017) Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?. Neurobiology of Disease 97, pages 156-168.
Crossref
Crossref
Carlos B. Mantilla. (2017) Gene therapy and respiratory neuroplasticity. Experimental Neurology 287, pages 261-267.
Crossref
Crossref
S.F. Kazim & K. Iqbal. 2017. Neuroprotection in Alzheimer's Disease. Neuroprotection in Alzheimer's Disease
3
29
.
Kristi M. Anderson & R. Lee Mosley. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
681
711
.
Chaoyang Liu, Chi Bun Chan & Keqiang Ye. (2016) 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Translational Neurodegeneration 5:1.
Crossref
Crossref
Syed Faraz Kazim & Khalid Iqbal. (2016) Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease. Molecular Neurodegeneration 11:1.
Crossref
Crossref
Aren Bezdjian, Véronique Kraaijenga, Dyan Ramekers, Huib Versnel, Hans Thomeer, Sjaak Klis & Wilko Grolman. (2016) Towards Clinical Application of Neurotrophic Factors to the Auditory Nerve; Assessment of Safety and Efficacy by a Systematic Review of Neurotrophic Treatments in Humans. International Journal of Molecular Sciences 17:12, pages 1981.
Crossref
Crossref
Jingjing He, Zheng Xiang, Xiaoqing Zhu, Zongyong Ai, Jingsong Shen, Tianzhuang Huang, Liegang Liu, Weizhi Ji & Tianqing Li. (2016) Neuroprotective Effects of 7, 8-dihydroxyflavone on Midbrain Dopaminergic Neurons in MPP+-treated Monkeys. Scientific Reports 6:1.
Crossref
Crossref
Xiao-Huan Li, Chun-Fang Dai, Long Chen, Wei-Tao Zhou, Hui-Li Han & Zhi-Fang Dong. (2016)
7,8-dihydroxyflavone Ameliorates Motor Deficits Via Suppressing
α
-synuclein Expression and Oxidative Stress in the MPTP-induced Mouse Model of Parkinson's Disease
. CNS Neuroscience & Therapeutics 22:7, pages 617-624.
Crossref
Crossref
Luther C. Gill, Heather M. Gransee, Gary C. Sieck & Carlos B. Mantilla. (2016) Functional recovery after cervical spinal cord injury: Role of neurotrophin and glutamatergic signaling in phrenic motoneurons. Respiratory Physiology & Neurobiology 226, pages 128-136.
Crossref
Crossref
Ji Hea Yu, Jung-Hwa Seo, Ji Yong Lee, Min-Young Lee & Sung-Rae Cho. (2016) Induction of Neurorestoration from Endogenous Stem Cells. Cell Transplantation 25:5, pages 863-882.
Crossref
Crossref
Sonya Kaur, Mitzi M. Gonzales, Takashi Tarumi, Astrid Villalpando, Mohammed Alkatan, Martha Pyron, Hirofumi Tanaka & Andreana P. Haley. (2016) Serum Brain-Derived Neurotrophic Factor Mediates the Relationship between Abdominal Adiposity and Executive Function in Middle Age. Journal of the International Neuropsychological Society 22:5, pages 493-500.
Crossref
Crossref
Dandan Luo, Ying Shi, Jun Wang, Qing Lin, Yi Sun, Keqiang Ye, Qiao Yan & Hai Zhang. (2016) 7,8-dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents. Neuroscience Letters 620, pages 43-49.
Crossref
Crossref
Nadia Mazzaro, Erica Barini, Maria Grazia Spillantini, Michel Goedert, Paolo Medini & Laura Gasparini. (2016) Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy. The Journal of Neuroscience 36:7, pages 2086-2100.
Crossref
Crossref
Martin F. Bjurstrom, Sarah E. Giron & Charles A. Griffis. (2016) Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review. Pain Practice 16:2, pages 183-203.
Crossref
Crossref
Lucio Tremolizzo, Andrea Pellegrini, Elisa Conti, Alessandro Arosio, Francesca Gerardi, Christian Lunetta, Paolo Magni, Ildebrando Appollonio & Carlo Ferrarese. (2016) BDNF Serum Levels with Respect to Multidimensional Assessment in Amyotrophic Lateral Sclerosis. Neurodegenerative Diseases 16:3-4, pages 192-198.
Crossref
Crossref
Jian Xu, Pradeep Kurup, Garikoitz Azkona, Tyler D. Baguley, Ana Saavedra, Angus C. Nairn, Jonathan A. Ellman, Esther Pérez‐Navarro & Paul J. Lombroso. (2015)
Down‐regulation of
BDNF
in cell and animal models increases striatal‐enriched protein tyrosine phosphatase 61 (
STEP
61
) levels
. Journal of Neurochemistry 136:2, pages 285-294.
Crossref
Crossref
Cumara B. O'Carroll, Amelia K. Adcock & Bart M. Demaerschalk. 2015. Evidence‐Based Neurology: Management of Neurological Disorders. Evidence‐Based Neurology: Management of Neurological Disorders
219
234
.
M.D. Sconce, M.J. Churchill, C. Moore & C.K. Meshul. (2015) Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson’s disease. Neuroscience 290, pages 454-471.
Crossref
Crossref
Zamanzima Mazibuko, Yahya E. Choonara, Pradeep Kumar, Lisa C. Du Toit, Girish Modi, Dinesh Naidoo & Viness Pillay. (2015) A Review of the Potential Role of Nano-Enabled Drug Delivery Technologies in Amyotrophic Lateral Sclerosis: Lessons Learned from Other Neurodegenerative Disorders. Journal of Pharmaceutical Sciences 104:4, pages 1213-1229.
Crossref
Crossref
Heather M. GranseeWen-Zhi ZhanGary C. SieckCarlos B. Mantilla. (2015) Localized Delivery of Brain-Derived Neurotrophic Factor-Expressing Mesenchymal Stem Cells Enhances Functional Recovery following Cervical Spinal Cord Injury. Journal of Neurotrauma 32:3, pages 185-193.
Crossref
Crossref
Helios Pareja-Galeano, Rafael Alis, Fabian Sanchis-Gomar, Helena Cabo, José Cortell-Ballester, Mari Carmen Gomez-Cabrera, Alejandro Lucia & José Viña. (2015) Methodological considerations to determine the effect of exercise on brain-derived neurotrophic factor levels. Clinical Biochemistry 48:3, pages 162-166.
Crossref
Crossref
Khanh vinh quốc Lương & Lan Thi Hoàng Nguyễn. 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease
261
279
.
Anup Tuladhar, Nikolaos Mitrousis, Tobias Führmann & Molly S. Shoichet. 2015. Translational Regenerative Medicine. Translational Regenerative Medicine
415
435
.
Lingbin Meng, Xiaolei Chen, Rongqiang Yang & Rui Ji. (2014) Role of BDNF in the taste system. Frontiers in Biology 9:6, pages 481-488.
Crossref
Crossref
Zhourui Wu, Ziru Zhao, Yan Yu, Xiao Hu, Wei Xu, Zhili Zeng, Yi Eve Sun & Liming Cheng. (2014) New strategies for the repair of spinal cord injury. Chinese Science Bulletin 59:31, pages 4041-4049.
Crossref
Crossref
Silvia Bolognin, Mario Buffelli, Jukka Puoliväli & Khalid Iqbal. (2014) Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiology of Aging 35:9, pages 2134-2146.
Crossref
Crossref
Xiang Yi, Devika S. Manickam, Anna Brynskikh & Alexander V. Kabanov. (2014) Agile delivery of protein therapeutics to CNS. Journal of Controlled Release 190, pages 637-663.
Crossref
Crossref
Xiaowei W. Su, James R. Broach, James R. Connor, Glenn S. Gerhard & Zachary Simmons. (2014) Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle & Nerve 49:6, pages 786-803.
Crossref
Crossref
Barış Genç & P. Hande Özdinler. (2014) Moving forward in clinical trials for ALS: motor neurons lead the way please. Drug Discovery Today 19:4, pages 441-449.
Crossref
Crossref
Gab Seok Kim, Seongeun Cho, James W. Nelson, Gregory J. Zipfel & Byung Hee Han. (2014) TrkB Agonist Antibody Pretreatment Enhances Neuronal Survival and Long-Term Sensory Motor Function Following Hypoxic Ischemic Injury in Neonatal Rats. PLoS ONE 9:2, pages e88962.
Crossref
Crossref
Daniel Todd, Ian Gowers, Simon J. Dowler, Michael D. Wall, George McAllister, David F. Fischer, Sipke Dijkstra, Silvina A. Fratantoni, Rhea van de Bospoort, Jessica Veenman-Koepke, Geraldine Flynn, Jamshid Arjomand, Celia Dominguez, Ignacio Munoz-Sanjuan, John Wityak & Jonathan A. Bard. (2014) A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease. PLoS ONE 9:2, pages e87923.
Crossref
Crossref
Zhentao Zhang, Xia Liu, Jason P Schroeder, Chi-Bun Chan, Mingke Song, Shan Ping Yu, David Weinshenker & Keqiang Ye. (2013) 7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease. Neuropsychopharmacology 39:3, pages 638-650.
Crossref
Crossref
Chiara Zuccato & Elena Cattaneo. 2014. Neurotrophic Factors. Neurotrophic Factors
357
409
.
Mary-Louise Rogers. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1755
1785
.
QINLIANG LI, YI LIU, ZHAOMING CHU, JINCHUAN CHEN, FENGLEI DAI, XIAORONG ZHU, ANKANG HU & CAI YUN. (2013) Brain-derived neurotrophic factor expression in dorsal root ganglia of a lumbar spinal stenosis model in rats. Molecular Medicine Reports 8:6, pages 1836-1844.
Crossref
Crossref
Yan-Yan He, Xiao-Yang Zhang, Wing-Ho Yung, Jing-Ning Zhu & Jian-Jun Wang. (2013) Role of BDNF in Central Motor Structures and Motor Diseases. Molecular Neurobiology 48:3, pages 783-793.
Crossref
Crossref
Philip Van Damme & Wim Robberecht. (2013) Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis. Current Opinion in Neurology 26:5, pages 466-472.
Crossref
Crossref
Teresa Tsai, Alice Klausmeyer, Rebecca Conrad, Christine Gottschling, Markus Leo, Andreas Faissner & Stefan Wiese. (2013) 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways. Molecular and Cellular Neuroscience 56, pages 18-28.
Crossref
Crossref
Thomas BucherMarie-Anne ColleErin WakelingLaurence DubreilJohn FyfeDelphine Briot-NivardMaud MaquigneauSylvie RaoulYan CherelStéphanie AstordSandra DuqueThibaut MaraisThomas VoitPhilippe MoullierMartine BarkatsBéatrice Joussemet. (2013) scAAV9 Intracisternal Delivery Results in Efficient Gene Transfer to the Central Nervous System of a Feline Model of Motor Neuron Disease. Human Gene Therapy 24:7, pages 670-682.
Crossref
Crossref
Bai Lu, Guhan Nagappan, Xiaoming Guan, Pradeep J. Nathan & Paul Wren. (2013) BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nature Reviews Neuroscience 14:6, pages 401-416.
Crossref
Crossref
T. Verhovshek, L.M. Rudolph & D.R. Sengelaub. (2013) Brain-derived neurotrophic factor and androgen interactions in spinal neuromuscular systems. Neuroscience 239, pages 103-114.
Crossref
Crossref
Mikhail I. Papisov, Vasily V. Belov & Kimberley S. Gannon. (2013) Physiology of the Intrathecal Bolus: The Leptomeningeal Route for Macromolecule and Particle Delivery to CNS. Molecular Pharmaceutics 10:5, pages 1522-1532.
Crossref
Crossref
Shelley J. Allen, Judy J. Watson, Deborah K. Shoemark, Neil U. Barua & Nikunj K. Patel. (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacology & Therapeutics 138:2, pages 155-175.
Crossref
Crossref
Fred Lühder, Ralf Gold, Alexander Flügel & Ralf A. Linker. (2013) Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models. Archivum Immunologiae et Therapiae Experimentalis 61:2, pages 95-105.
Crossref
Crossref
Nicole L. Nichols, Genevieve Gowing, Irawan Satriotomo, Lisa J. Nashold, Erica A. Dale, Masatoshi Suzuki, Pablo Avalos, Patrick L. Mulcrone, Jacalyn McHugh, Clive N. Svendsen & Gordon S. Mitchell. (2013) Intermittent Hypoxia and Stem Cell Implants Preserve Breathing Capacity in a Rodent Model of Amyotrophic Lateral Sclerosis. American Journal of Respiratory and Critical Care Medicine 187:5, pages 535-542.
Crossref
Crossref
Chen Benkler, Tali Ben-Zur, Yael Barhum & Daniel Offen. (2013)
Altered astrocytic response to activation in SOD1
G93A
mice and its implications on amyotrophic lateral sclerosis pathogenesis
. Glia 61:3, pages 312-326.
Crossref
Crossref
Marzia Soligo, Stefania Lucia Nori, Virginia Protto, Fulvio Florenzano & Luigi Manni. 2013. Neurobiology of Acupuncture. Neurobiology of Acupuncture
91
124
.
Chen Benkler, Daniel Offen, Eldad Melamed, Tamar Amit, Silvia Mandel, Moussa B. H. Youdim & Orly Weinreb. 2013. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future
235
274
.
April M Weissmiller & Chengbiao Wu. (2012) Current advances in using neurotrophic factors to treat neurodegenerative disorders. Translational Neurodegeneration 1:1.
Crossref
Crossref
Leyan XuVasiliki Mahairaki & Vassilis E Koliatsos. (2012) Host induction by transplanted neural stem cells in the spinal cord: further evidence for an adult spinal cord neurogenic niche. Regenerative Medicine 7:6, pages 785-797.
Crossref
Crossref
Y. Z. Huang, F. J. Hernandez, B. Gu, K. R. Stockdale, K. Nanapaneni, T. E. Scheetz, M. A. Behlke, A. S. Peek, T. Bair, P. H. Giangrande & J. O. McNamara. (2012) RNA Aptamer-Based Functional Ligands of the Neurotrophin Receptor, TrkB. Molecular Pharmacology 82:4, pages 623-635.
Crossref
Crossref
Jorge A. Quiroz, Guang Chen, Wayne C. Drevets, Ioline D. Henter & Husseini K. Manji. 2012. Translational Neuroscience. Translational Neuroscience
27
79
.
Qing Yu, Qing Chang, Xia Liu, Shusheng Gong, Keqiang Ye & Xi Lin. (2012) 7,8,3′-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivo. Biochemical and Biophysical Research Communications 422:3, pages 387-392.
Crossref
Crossref
Reto Baldinger, Hans Dieter Katzberg & Markus Weber. (2012) Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Gilmore N. O’Neill. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
19
27
.
. 2012. Clinical Trials in Neurology. Clinical Trials in Neurology
1
27
.
J. M. Pizarro, W. E. Chang, M. J. Bah, L. K. M. Wright, G. A. Saviolakis, A. Alagappan, C. L. Robison, J. D. Shah, J. L. Meyerhoff, D. M. Cerasoli, E. G. Midboe & L. A. Lumley. (2012) Repeated Exposure to Sublethal Doses of the Organophosphorus Compound VX Activates BDNF Expression in Mouse Brain. Toxicological Sciences 126:2, pages 497-505.
Crossref
Crossref
Peter M. Andersen, Sharon Abrahams, Gian D. Borasio, Mamede de Carvalho, Adriano Chio, Philip Van Damme, Orla Hardiman, Katja Kollewe, Karen E. Morrison, Susanne Petri, Pierre‐Francois Pradat, Vincenzo Silani, Barbara Tomik, Maria Wasner & Markus Weber. (2011) EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force. European Journal of Neurology 19:3, pages 360-375.
Crossref
Crossref
Andrew R. MendelsohnJames W. Larrick. (2012) Epigenetic-Mediated Decline in Synaptic Plasticity During Aging. Rejuvenation Research 15:1, pages 98-101.
Crossref
Crossref
Carlos B. Mantilla & Leonid G. Ermilov. (2012) The novel TrkB receptor agonist 7,8-dihydroxyflavone enhances neuromuscular transmission. Muscle & Nerve 45:2, pages 274-276.
Crossref
Crossref
Bogusław Machaliñski, Piotr Łażewski-Banaszak, Elżbieta Dąbkowska, Edyta Paczkowska, Monika Gołąb-Janowska & Przemysław Nowacki. (2012) Rola czynników neurotroficznych w procesach regeneracji układu nerwowego. Neurologia i Neurochirurgia Polska 46:6, pages 579-590.
Crossref
Crossref
Jeffrey S. Kroin & Asokumar Buvanendran. 2012. Intrathecal Drug Delivery for Pain and Spasticity�. Intrathecal Drug Delivery for Pain and Spasticity�
3
13
.
B. Ruozi, D. Belletti, L. Bondioli, A. De Vita, F. Forni, M.A. Vandelli & G. Tosi. 2012. New Perspectives of Central Nervous System Injury and Neuroprotection. New Perspectives of Central Nervous System Injury and Neuroprotection
207
247
.
Hans Rommelspacher. 2012. Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants. Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants
165
171
.
Stephen D. Skaper. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
P. BiginiP. VeglianeseG. AndrioloL. CovaG. GrignaschiI. CaronC. DalenoS. BarberaA. OttolinaC. CalzarossaL. LazzariT. MenniniC. BendottiV. Silani. (2011) Intracerebroventricular Administration of Human Umbilical Cord Blood Cells Delays Disease Progression in Two Murine Models of Motor Neuron Degeneration. Rejuvenation Research 14:6, pages 623-639.
Crossref
Crossref
Peter I. Joyce, Pietro Fratta, Elizabeth M. C. Fisher & Abraham Acevedo-Arozena. (2011) SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mammalian Genome 22:7-8, pages 420-448.
Crossref
Crossref
Thomas W. Gould & Ronald W. Oppenheim. (2011) Motor neuron trophic factors: Therapeutic use in ALS?. Brain Research Reviews 67:1-2, pages 1-39.
Crossref
Crossref
Mostafa Rahvar, Mohsen Nikseresht, Sayed Mohammad Shafiee, Fakhraddin Naghibalhossaini, Mozhgan Rasti, Mohammad Reza Panjehshahin & Ali Akbar Owji. (2011) Effect of Oral Resveratrol on the BDNF Gene Expression in the Hippocampus of the Rat Brain. Neurochemical Research 36:5, pages 761-765.
Crossref
Crossref
Alan H. Nagahara & Mark H. Tuszynski. (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nature Reviews Drug Discovery 10:3, pages 209-219.
Crossref
Crossref
Nanette Joyce & Gregory T. Carter. 2011. Physical Medicine and Rehabilitation. Physical Medicine and Rehabilitation
1041
1063
.
Antonio Lucio Teixeira, Izabela Guimarães Barbosa, Breno Satler Diniz & Arthur Kummer. (2010) Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers in Medicine 4:6, pages 871-887.
Crossref
Crossref
Nils Erik Gilhus, Michael P. Barnes & Michael BraininP. M. Andersen (chairman)S. Abrahams, G. D. Borasio, M. de Carvalho, A. Chio, P. Van Damme, O. Hardiman, K. Kollewe, K. E. Morrison, S. Petri, P. ‐F. Pradat, V. Silani, B. Tomik, M. Wasner & M. Weber. 2010. European Handbook of Neurological Management. European Handbook of Neurological Management
283
310
.
Sven G. Meuth, Stefan Bittner, Jochen C. Ulzheimer, Christoph Kleinschnitz, Bernd C. Kieseier & Heinz Wiendl. (2010) Therapeutic Approaches to Multiple Sclerosis. BioDrugs 24:5, pages 317-330.
Crossref
Crossref
Sung-Wuk Jang, Xia Liu, Chi Bun Chan, Stefan A. France, Iqbal Sayeed, Wenxue Tang, Xi Lin, Ge Xiao, Raul Andero, Qiang Chang, Kerry J. Ressler & Keqiang Ye. (2010) Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice. PLoS ONE 5:7, pages e11528.
Crossref
Crossref
Chiara Zuccato, Marta Valenza & Elena Cattaneo. (2010) Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease. Physiological Reviews 90:3, pages 905-981.
Crossref
Crossref
Chen Benkler, Daniel Offen, Eldad Melamed, Lana Kupershmidt, Tamar Amit, Silvia Mandel, Moussa B. H. Youdim & Orly Weinreb. (2010) Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application. EPMA Journal 1:2, pages 343-361.
Crossref
Crossref
Sung-Wuk Jang, Xia Liu, Manuel YepesKennie R. ShepherdGary W. MillerYang LiuW. David WilsonGe Xiao, Bruno Blanchi, Yi E. Sun & Keqiang Ye. (2010) A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proceedings of the National Academy of Sciences 107:6, pages 2687-2692.
Crossref
Crossref
John Kelly. 2010. Principles of CNS Drug Development. Principles of CNS Drug Development
245
286
.
J. Jefferson P. Perry, David S. Shin & John A. Tainer. 2010. Diseases of DNA Repair. Diseases of DNA Repair
9
20
.
Lokesh C Wijesekera & P Nigel Leigh. (2009) Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases 4:1.
Crossref
Crossref
Gary C. Sieck & Carlos B. Mantilla. (2009) Role of neurotrophins in recovery of phrenic motor function following spinal cord injury. Respiratory Physiology & Neurobiology 169:2, pages 218-225.
Crossref
Crossref
Stephen J O'Leary, Rachael R Richardson & Hugh J McDermott. (2009) Principles of design and biological approaches for improving the selectivity of cochlear implant electrodes. Journal of Neural Engineering 6:5, pages 055002.
Crossref
Crossref
Chiara Zuccato & Elena Cattaneo. (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology 5:6, pages 311-322.
Crossref
Crossref
Susanne Petri, Klaus Krampfl, Kerstin Kuhlemann, Reinhard Dengler & Claudia Grothe. (2008) Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients. Histochemistry and Cell Biology 131:4, pages 509-519.
Crossref
Crossref
Michael Benatar, Jerome Kurent & Dan H Moore. (2009) Treatment for familial amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Carlos B. Mantilla & Gary C. Sieck. (2008) Trophic factor expression in phrenic motor neurons. Respiratory Physiology & Neurobiology 164:1-2, pages 252-262.
Crossref
Crossref
Sanjay J Mathew, Husseini K Manji & Dennis S Charney. (2008) Novel Drugs and Therapeutic Targets for Severe Mood Disorders. Neuropsychopharmacology 33:9, pages 2080-2092.
Crossref
Crossref
B. Jane Distad, Gregg D. Meekins, Lee L. Liou, Michael D. Weiss, Gregory T. Carter & Robert G. Miller. (2008) Drug Therapy in Amyotrophic Lateral Sclerosis. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 633-651.
Crossref
Crossref
Gregory A. Cary & Albert R. La Spada. (2008) Androgen Receptor Function in Motor Neuron Survival and Degeneration. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 479-494.
Crossref
Crossref
Mauro CozzolinoAlberto FerriMaria Teresa Carrì. (2008) Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications. Antioxidants & Redox Signaling 10:3, pages 405-444.
Crossref
Crossref
Fabio Fumagalli, Raffaella Molteni, Francesca Calabrese, Paola Francesca Maj, Giorgio Racagni & Marco Andrea Riva. (2008) Neurotrophic Factors in Neurodegenerative Disorders. CNS Drugs 22:12, pages 1005-1019.
Crossref
Crossref
EUGENE M. JOHNSONJR.JR. & MARK H. TUSZYNSKI. 2008. CNS Regeneration. CNS Regeneration
95
144
.
Aya Ishigaki, Masashi Aoki, Makiko Nagai, Hitoshi Warita, Shinsuke Kato, Masako Kato, Toshikazu Nakamura, Hiroshi Funakoshi & Yasuto Itoyama. (2007) Intrathecal Delivery of Hepatocyte Growth Factor From Amyotrophic Lateral Sclerosis Onset Suppresses Disease Progression in Rat Amyotrophic Lateral Sclerosis Model. Journal of Neuropathology & Experimental Neurology 66:11, pages 1037-1044.
Crossref
Crossref
Ian M. MacDonald, Yves Sauvé & Paul A. Sieving. (2007) Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants. Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie 42:3, pages 399-402.
Crossref
Crossref
JD Mitchell & GD Borasio. (2007) Amyotrophic lateral sclerosis. The Lancet 369:9578, pages 2031-2041.
Crossref
Crossref
Douglas Mitchell. 2007. Evidence‐based Neurology: Management of Neurological Disorders. Evidence‐based Neurology: Management of Neurological Disorders
234
243
.
Mamatha S. Nayak, Yun-Sook Kim, Michelle Goldman, Hans S. Keirstead & Douglas A. Kerr. (2006) Cellular therapies in motor neuron diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1762:11-12, pages 1128-1138.
Crossref
Crossref
Ming D. Qian, Jie Zhang, Xiang-Yang Tan, Andrew Wood, Davinder Gill & Seongeun Cho. (2006) Novel Agonist Monoclonal Antibodies Activate TrkB Receptors and Demonstrate Potent Neurotrophic Activities. The Journal of Neuroscience 26:37, pages 9394-9403.
Crossref
Crossref
Susan G. Dorsey, Cynthia L. Renn, Laura Carim-Todd, Colleen A. Barrick, Linda Bambrick, Bruce K. Krueger, Christopher W. Ward & Lino Tessarollo. (2006) In Vivo Restoration of Physiological Levels of Truncated TrkB.T1 Receptor Rescues Neuronal Cell Death in a Trisomic Mouse Model. Neuron 51:1, pages 21-28.
Crossref
Crossref
Carlos A. ZarateJrJr, Jaskaran Singh & Husseini K. Manji. (2006) Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder. Biological Psychiatry 59:11, pages 1006-1020.
Crossref
Crossref
P. Cintas. (2006) Quels sont les traitements médicamenteux étiologiques?. Revue Neurologique 162, pages 220-227.
Crossref
Crossref
Elizabeth Vernon Pitts, Srilatha Potluri, Darren M. Hess & Rita J. Balice-Gordon. (2006) Neurotrophin and Trk-mediated Signaling in the Neuromuscular System. International Anesthesiology Clinics 44:2, pages 21-76.
Crossref
Crossref
Thais Federici & Nicholas M. Boulis. (2006) Gene-based treatment of motor neuron diseases. Muscle & Nerve 33:3, pages 302-323.
Crossref
Crossref
Displaying 200 of 229 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list